Over the longer term I agree, but it may be a bit premature to draw that conclusion from the most recent 4C, particularly noting:
- License packs will have a new minimum of 200 users (ensuring future contracts will have a greater impact on revenue than previously);
- There are almost 3 estimated quarters of funding remaining;
- The cyber security theme is attracting significant attention; and
- The potential pipeline, if executed properly will be well received and reflected in the future price.
- Forums
- ASX - By Stock
- AR9
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-27
-
- There are more pages in this discussion • 366 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AR9 (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.7¢ |
Change
-0.001(1.28%) |
Mkt cap ! $22.07M |
Open | High | Low | Value | Volume |
7.7¢ | 7.7¢ | 7.7¢ | $5.562K | 72.23K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 154222 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 126614 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 154222 | 0.077 |
2 | 60000 | 0.076 |
9 | 424409 | 0.075 |
1 | 13513 | 0.074 |
1 | 30000 | 0.072 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 126614 | 2 |
0.081 | 7478 | 1 |
0.082 | 11278 | 2 |
0.083 | 78636 | 4 |
0.084 | 19500 | 1 |
Last trade - 09.59am 03/07/2024 (20 minute delay) ? |
Featured News
AR9 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online